Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 2003

View Archived Issues

Antiobesity effects of IL-6 in rodents

Anti-HIV effects described for green tea component

Antiinflammatory activity of AVR-118 demonstrated in animal model and clinical trial

MMV, Immtech and U. of North Carolina to develop DB-289 for malaria

GW-873140 completes phase I testing

Development agreement for MDTS formulations of Nestorone

Protherics: six-month progress report

Factor Xa inhibitor from Lilly/Tularik collaboration enters phase II

Enrollment to begin in phase I/II trial of CB-001

Novel peptide deformylase inhibitor drug candidate enters phase I

Indena claims two series of hyperforin derivatives for depression and AD

Novel antimycobacterial agents designed at U. of Central Florida

New prodrugs of LY-293558 with AMPA- and GluR5-antagonist activity covered by Lilly patent

New NR2B NMDA antagonist and its use reported by Pfizer team

Altana describes dual NO-donating gastric antisecretory agents

Novel cysteine protease inhibitors in early development at Ono

Isatoribine biologically active in HCV patients in phase Ib trial

Cyclacel acquires rights to CYC-682

EHT-0202 enters phase I study

Risperdal approved for bipolar mania

Binodenoson enters phase III

Avastin submitted for approval in Europe for colorectal cancer

Fast track status granted for HspE7 in recurrent respiratory papillomatosis

Dual-acting estrogen sulfatase inhibitor and SERM presented in San Antonio

JNJ-6368661 characterized as potent, orally active anticoagulant and antithrombotic agent

Selective platelet TP receptor antagonist BM-613 synthesized by Belgian researchers

S-40503: a novel SARM with selective effects on bone in rat models of osteoporosis

hTERT-based vaccine approaches to breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...